Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Psychotropic drug use in Italy, 1984-99: the impact of a change in reimbursement status
Autore:
Barbui, C; Campomori, A; Mezzalira, L; Lopatriello, S; Da Cas, R; Garattini, S;
Indirizzi:
Ist Ric Farmacol Mario Negri, WHO, Collaborating Ctr Res & Training MentalHlth, Lab Epidemiol & Social Psychiat, I-20157 Milan, Italy Ist Ric Farmacol Mario Negri Milan Italy I-20157 t, I-20157 Milan, Italy CeVEAS, Modena, Italy CeVEAS Modena ItalyCeVEAS, Modena, Italy Osservatorio Farmaci SIFO, Verona, Italy Osservatorio Farmaci SIFO Verona Italy orio Farmaci SIFO, Verona, Italy Ist Super Sanita, I-00161 Rome, Italy Ist Super Sanita Rome Italy I-00161 st Super Sanita, I-00161 Rome, Italy
Titolo Testata:
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
fascicolo: 4, volume: 16, anno: 2001,
pagine: 227 - 233
SICI:
0268-1315(200107)16:4<227:PDUII1>2.0.ZU;2-E
Fonte:
ISI
Lingua:
ENG
Soggetto:
SEROTONIN REUPTAKE INHIBITORS; TRICYCLIC ANTIDEPRESSANTS; ATYPICAL ANTIPSYCHOTICS; PRESCRIPTION DATABASE; BENZODIAZEPINE USE; GENERAL-PRACTICE; PRIMARY-CARE; SCHIZOPHRENIA; CLOZAPINE; METAANALYSIS;
Keywords:
antidepressants; antipsychotics; benzodiazepines; prescriptions; psychotropic drugs;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
51
Recensione:
Indirizzi per estratti:
Indirizzo: Barbui, C Ist Ric Farmacol Mario Negri, WHO, Collaborating Ctr Res & Training MentalHlth, Lab Epidemiol & Social Psychiat, Via Eritrea 62, I-20157 Milan, Italy Ist Ric Farmacol Mario Negri Via Eritrea 62 Milan Italy I-20157
Citazione:
C. Barbui et al., "Psychotropic drug use in Italy, 1984-99: the impact of a change in reimbursement status", INT CLIN PS, 16(4), 2001, pp. 227-233

Abstract

After years of corruption surrounding drug reimbursement, in 1994, a change in drug reimbursement status was implemented in Italy according to cost-effectiveness criteria. The aim of this study was to assess the impact of these changes on the use of psychotropic drugs. National trends in antipsychotic, antidepressant and benzodiazepine prescriptions were analysed from 1984 to 1999. During the study period, prescriptions of antipsychotic drugs were stable from 1984 to 1994 but, in the subsequent 5 years, increased by 54%. Although the use of atypical compounds in 1999 accounted for only 6% of total antipsychotics sold, the cost of these new drugs accounted for almostone-half the total antipsychotic expenditure. The use of benzodiazepines increased by 53%. In 1999, the psychotropic drugs lorazepam and alprazolam were the most sold by value. From 1984 to 1999, the total antidepressants sold increased by 55%. Although the use of selective serotonin reuptake inhibitors and newer antidepressants in 1999 accounted for less than 50% of total antidepressants sold, the cost of these drugs accounted for 65% of total antidepressant expenditure. This analysis highlights specific areas of concern which should become the object of public health programs. (C) 2001 Lippincott Williams & Wilkins.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/20 alle ore 04:42:23